Article
ZHX2 Promotes HIF1α Oncogenic Signaling in Triple-Negative Breast Cancer
medRxiv · 2021 · Fang, W.; Liao, C.; Shi, R.; Simon, J.; Ptacek, T.; Zurlo, G.; Ye, Y.; Han, L.; Fan, C.; Ortiz, C. L.; Lin, H.-R.; Manocha, U.; Luo, W.; Kim, W. Y.; Yang, L.-W.; Zhang, Q.
Key facts
| Title | ZHX2 Promotes HIF1α Oncogenic Signaling in Triple-Negative Breast Cancer |
|---|---|
| First author | Fang, W.; Liao, C.; Shi, R.; Simon, J.; Ptacek, T.; Zurlo, G.; Ye, Y.; Han, L.; Fan, C.; Ortiz, C. L.; Lin, H.-R.; Manocha, U.; Luo, W.; Kim, W. Y.; Yang, L.-W.; Zhang, Q. |
| Journal | medRxiv |
| Published | May 28, 2021 |
| DOI | 10.1101/2021.05.27.445959 |
| Devices mentioned | BK110039, DEN000008, K022086, K103302 |
| Product codes mentioned | JCI, JJH, KIP, KIT, MVU, NDS, NJT, OOI, PFT, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1